These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34863304)

  • 1. Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden.
    Holm K; Lundgren MN; Kjeldsen-Kragh J; Ljungquist O; Böttiger B; Wikén C; Öberg J; Fernström N; Rosendal E; Överby AK; Wigren Byström J; Forsell M; Landin-Olsson M; Rasmussen M
    BMC Res Notes; 2021 Dec; 14(1):440. PubMed ID: 34863304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.
    Devos T; Geukens T; Schauwvlieghe A; Ariën KK; Barbezange C; Cleeren M; Compernolle V; Dauby N; Desmecht D; Grimaldi D; Lambrecht BN; Luyten A; Maes P; Moutschen M; Romano M; Seyler L; Nevessignsky MT; Vandenberghe K; van Griensven J; Verbeke G; Vlieghe E; Yombi JC; Liesenborghs L; Verhamme P; Meyfroidt G
    Trials; 2020 Nov; 21(1):981. PubMed ID: 33246499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
    Li L; Zhang W; Hu Y; Tong X; Zheng S; Yang J; Kong Y; Ren L; Wei Q; Mei H; Hu C; Tao C; Yang R; Wang J; Yu Y; Guo Y; Wu X; Xu Z; Zeng L; Xiong N; Chen L; Wang J; Man N; Liu Y; Xu H; Deng E; Zhang X; Li C; Wang C; Su S; Zhang L; Wang J; Wu Y; Liu Z
    JAMA; 2020 Aug; 324(5):460-470. PubMed ID: 32492084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
    Self WH; Stewart TG; Wheeler AP; El Atrouni W; Bistran-Hall AJ; Casey JD; Cataldo VD; Chappell JD; Cohn CS; Collins JB; Denison MR; de Wit M; Dixon SL; Duggal A; Edwards TL; Fontaine MJ; Ginde AA; Harkins MS; Harrington T; Harris ES; Hoda D; Ipe TS; Jaiswal SJ; Johnson NJ; Jones AE; Laguio-Vila M; Lindsell CJ; Mallada J; Mammen MJ; Metcalf RA; Middleton EA; Mucha S; O'Neal HR; Pannu SR; Pulley JM; Qiao X; Raval JS; Rhoads JP; Schrager H; Shanholtz C; Shapiro NI; Schrantz SJ; Thomsen I; Vermillion KK; Bernard GR; Rice TW;
    Trials; 2021 Mar; 22(1):221. PubMed ID: 33743799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
    Bégin P; Callum J; Jamula E; Cook R; Heddle NM; Tinmouth A; Zeller MP; Beaudoin-Bussières G; Amorim L; Bazin R; Loftsgard KC; Carl R; Chassé M; Cushing MM; Daneman N; Devine DV; Dumaresq J; Fergusson DA; Gabe C; Glesby MJ; Li N; Liu Y; McGeer A; Robitaille N; Sachais BS; Scales DC; Schwartz L; Shehata N; Turgeon AF; Wood H; Zarychanski R; Finzi A; ; Arnold DM
    Nat Med; 2021 Nov; 27(11):2012-2024. PubMed ID: 34504336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis.
    Zeng J; Yin S; Du X; Song T; Lin T
    Transfus Clin Biol; 2021 Aug; 28(3):321-329. PubMed ID: 33839301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia.
    Thorlacius-Ussing L; Brooks PT; Nielsen H; Jensen BA; Wiese L; Sækmose SG; Johnsen S; Gybel-Brask M; Johansen IS; Bruun MT; Stærke NB; Østergaard L; Erikstrup C; Ostrowski SR; Homburg KM; Georgsen J; Mikkelsen S; Sandholdt H; Leding C; Hovmand N; Clausen CL; Tinggaard M; Pedersen KBH; Iversen KK; Tingsgård S; Israelsen SB; Benfield T
    Sci Rep; 2022 Sep; 12(1):16385. PubMed ID: 36180450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    ; Estcourt LJ; Turgeon AF; McQuilten ZK; McVerry BJ; Al-Beidh F; Annane D; Arabi YM; Arnold DM; Beane A; Bégin P; van Bentum-Puijk W; Berry LR; Bhimani Z; Birchall JE; Bonten MJM; Bradbury CA; Brunkhorst FM; Buxton M; Callum JL; Chassé M; Cheng AC; Cove ME; Daly J; Derde L; Detry MA; De Jong M; Evans A; Fergusson DA; Fish M; Fitzgerald M; Foley C; Goossens H; Gordon AC; Gosbell IB; Green C; Haniffa R; Harvala H; Higgins AM; Hills TE; Hoad VC; Horvat C; Huang DT; Hudson CL; Ichihara N; Laing E; Lamikanra AA; Lamontagne F; Lawler PR; Linstrum K; Litton E; Lorenzi E; MacLennan S; Marshall J; McAuley DF; McDyer JF; McGlothlin A; McGuinness S; Miflin G; Montgomery S; Mouncey PR; Murthy S; Nichol A; Parke R; Parker JC; Priddee N; Purcell DFJ; Reyes LF; Richardson P; Robitaille N; Rowan KM; Rynne J; Saito H; Santos M; Saunders CT; Serpa Neto A; Seymour CW; Silversides JA; Tinmouth AA; Triulzi DJ; Turner AM; van de Veerdonk F; Walsh TS; Wood EM; Berry S; Lewis RJ; Menon DK; McArthur C; Zarychanski R; Angus DC; Webb SA; Roberts DJ; Shankar-Hari M
    JAMA; 2021 Nov; 326(17):1690-1702. PubMed ID: 34606578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
    Alemany A; Millat-Martinez P; Corbacho-Monné M; Malchair P; Ouchi D; Ruiz-Comellas A; Ramírez-Morros A; Rodríguez Codina J; Amado Simon R; Videla S; Costes G; Capdevila-Jáuregui M; Torrano-Soler P; San José A; Bonet Papell G; Puig J; Otero A; Ruibal Suarez JC; Zarauza Pellejero A; Llopis Roca F; Rodriguez Cortez O; Garcia Garcia V; Vidal-Alaball J; Millan A; Contreras E; Grifols JR; Ancochea À; Galvan-Femenia I; Piccolo Ferreira F; Bonet M; Cantoni J; Prat N; Ara J; Forcada Arcarons A; Farré M; Pradenas E; Blanco J; Àngel Rodriguez-Arias M; Fernández Rivas G; Marks M; Bassat Q; Blanco I; Baro B; Clotet B; Mitjà O;
    Lancet Respir Med; 2022 Mar; 10(3):278-288. PubMed ID: 35150610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia: A Randomized Clinical Trial.
    Menichetti F; Popoli P; Puopolo M; Spila Alegiani S; Tiseo G; Bartoloni A; De Socio GV; Luchi S; Blanc P; Puoti M; Toschi E; Massari M; Palmisano L; Marano G; Chiamenti M; Martinelli L; Franchi S; Pallotto C; Suardi LR; Luciani Pasqua B; Merli M; Fabiani P; Bertolucci L; Borchi B; Modica S; Moneta S; Marchetti G; d'Arminio Monforte A; Stoppini L; Ferracchiato N; Piconi S; Fabbri C; Beccastrini E; Saccardi R; Giacometti A; Esperti S; Pierotti P; Bernini L; Bianco C; Benedetti S; Lanzi A; Bonfanti P; Massari M; Sani S; Saracino A; Castagna A; Trabace L; Lanza M; Focosi D; Mazzoni A; Pistello M; Falcone M;
    JAMA Netw Open; 2021 Nov; 4(11):e2136246. PubMed ID: 34842924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
    O'Donnell MR; Grinsztejn B; Cummings MJ; Justman JE; Lamb MR; Eckhardt CM; Philip NM; Cheung YK; Gupta V; João E; Pilotto JH; Diniz MP; Cardoso SW; Abrams D; Rajagopalan KN; Borden SE; Wolf A; Sidi LC; Vizzoni A; Veloso VG; Bitan ZC; Scotto DE; Meyer BJ; Jacobson SD; Kantor A; Mishra N; Chauhan LV; Stone EF; Dei Zotti F; La Carpia F; Hudson KE; Ferrara SA; Schwartz J; Stotler BA; Lin WW; Wontakal SN; Shaz B; Briese T; Hod EA; Spitalnik SL; Eisenberger A; Lipkin WI
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33974559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.
    Bennett-Guerrero E; Romeiser JL; Talbot LR; Ahmed T; Mamone LJ; Singh SM; Hearing JC; Salman H; Holiprosad DD; Freedenberg AT; Carter JA; Browne NJ; Cosgrove ME; Shevik ME; Generale LM; Andrew MA; Nachman S; Fries BC; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2021 Jul; 49(7):1015-1025. PubMed ID: 33870923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
    Simonovich VA; Burgos Pratx LD; Scibona P; Beruto MV; Vallone MG; Vázquez C; Savoy N; Giunta DH; Pérez LG; Sánchez MDL; Gamarnik AV; Ojeda DS; Santoro DM; Camino PJ; Antelo S; Rainero K; Vidiella GP; Miyazaki EA; Cornistein W; Trabadelo OA; Ross FM; Spotti M; Funtowicz G; Scordo WE; Losso MH; Ferniot I; Pardo PE; Rodriguez E; Rucci P; Pasquali J; Fuentes NA; Esperatti M; Speroni GA; Nannini EC; Matteaccio A; Michelangelo HG; Follmann D; Lane HC; Belloso WH;
    N Engl J Med; 2021 Feb; 384(7):619-629. PubMed ID: 33232588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol.
    Misset B; Hoste E; Donneau AF; Grimaldi D; Meyfroidt G; Moutschen M; Compernolle V; Gothot A; Desmecht D; Garigliany M; Najdovski T; Laterre PF
    BMC Pulm Med; 2020 Dec; 20(1):317. PubMed ID: 33287790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.